Get started
Author

Carla Estany

Observed names: C Estany, C. Estany Quera, Carla Estany Quera, Carla Estany-Quera, Estany Carla, Estany, C.
ORCID: 0000-0001-6993-5865
Observed ORCID: 0000-0001-6993-5865
OpenAlex ID: A5087975641
Gut Microbiota Linked to Sexual Preference and HIV Infection
2016 · Marc Noguera-Julian, Muntsa Rocafort, et al. · EBioMedicine · 445
PDF
High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study
2010 · Anna Bonjoch, Marta Figueras, et al. · AIDS · 167
The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial
2015 · José R. Santos, María Saumoy, et al. · Clinical Infectious Diseases · 138
PDF
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
2023 · Lourdes Mateu, Cristian Tebe, et al. · The Lancet Regional Health - Europe · 104
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection
2018 · Yolanda Guillén, Marc Noguera-Julian, et al. · Mucosal Immunology · 91
PDF
Reconstructive Treatment for Antiretroviral-Associated Facial Lipoatrophy: A Prospective Study Comparing Autologous Fat and Synthetic Substances
2006 · Eugenia Negredo, Carmen Higueras, et al. · AIDS Patient Care and STDs · 58
High Prevalence of Sarcopenia in HIV-Infected Individuals
2018 · Patricia Echeverría, Anna Bonjoch, et al. · BioMed Research International · 57
PDF
Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse‐Transcriptase Inhibitor–Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)
2009 · Eugenia Negredo, Òscar Miró, et al. · Clinical Infectious Diseases · 48
PDF
High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy
2012 · Anna Bonjoch, Patricia Echeverría, et al. · Antiviral Research · 47
Vagus nerve dysfunction in the post–COVID-19 condition: a pilot cross-sectional study
2023 · Gemma Lladós, Marta Massanella, et al. · Clinical Microbiology and Infection · 35
PDF
A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction
2020 · Jordi Puig, Patricia Echeverría, et al. · Telemedicine Journal and e-Health · 32
Four-Year Safety with Polyacrylamide Hydrogel to Correct Antiretroviral-Related Facial Lipoatrophy
2009 · Eugenia Negredo, Jordi Puig, et al. · AIDS Research and Human Retroviruses · 29
Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort
2010 · Anna Bonjoch, Beatriz Bayés, et al. · Antiviral Research · 27
Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan
2012 · Eugenia Negredo, Anna Bonjoch, et al. · PLoS ONE · 25
PDF
Comparison of two different strategies of treatment with zoledronate in HIV ‐infected patients with low bone mineral density: single dose versus two doses in 2 years
2015 · E Negredo, A Bonjoch, et al. · HIV Medicine · 20
Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial
2025 · Sergio España-Cueto, Cora Loste, et al. · Nature Communications · 19
Potential prescribing issues among older HIV‐infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern?
2020 · Cora Loste, José Moltó, et al. · British Journal of Clinical Pharmacology · 16
Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients
2015 · Eugenia Negredo, Jordi Puig, et al. · AIDS Research and Human Retroviruses · 12
Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals
2016 · Eugènia Negredo, Vicente Estrada, et al. · Journal of Antimicrobial Chemotherapy · 11
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs
2018 · Eugènia Negredo, Klaus Langohr, et al. · Journal of Antimicrobial Chemotherapy · 9
Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity
2016 · Anna Bonjoch, Patricia Echeverría, et al. · BioMed Research International · 8
PDF
Therapeutic management of bone demineralization in the HIV-infected population
2007 · Eugènia Negredo, Eva Martínez, et al. · AIDS · 8
Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort)
2021 · Eugenia Negredo, Cora Loste, et al. · AIDS Care · 6
Randomized, crossover, double‐blind, placebo‐controlled trial to assess the lipid lowering effect of co‐formulated TDF/FTC
2014 · José Ramón Santos, María Saumoy, et al. · Journal of the International AIDS Society · 6
PDF
Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject.
2015 · Eugènia Negredo, Anna Bonjoch, et al. · PubMed · 5
Works count: 44
Citation count: 1,433
H-index: 16
I10-index: 19
Year
Topic
Type